BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

779 related articles for article (PubMed ID: 29468377)

  • 21. [Efficacy comparison among high risk factors questionnaire and Asia-Pacific colorectal screening score and their combinations with fecal immunochemical test in screening advanced colorectal tumor].
    Zhu N; Huang YQ; Song YM; Zhang SZ; Zheng S; Yuan Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jul; 25(7):612-620. PubMed ID: 35844124
    [No Abstract]   [Full Text] [Related]  

  • 22. Adenoma detection rate metrics in colorectal cancer surveillance colonoscopy.
    Tjaden JM; Hause JA; Berger D; Duveneck SK; Jakate SM; Orkin BA; Hubbard EL; Melson JE
    Surg Endosc; 2018 Jul; 32(7):3108-3113. PubMed ID: 29340817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adenoma and sessile serrated polyp detection rates: variation by patient sex and colonic segment but not specialty of the endoscopist.
    Sanaka MR; Gohel T; Podugu A; Kiran RP; Thota PN; Lopez R; Church JM; Burke CA
    Dis Colon Rectum; 2014 Sep; 57(9):1113-9. PubMed ID: 25101608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adenoma Detection Rate in Colonoscopy: Is Indication a Predictor?
    Yang PF; Wong SW
    Surg Laparosc Endosc Percutan Tech; 2016 Apr; 26(2):156-61. PubMed ID: 26813239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenoma and advanced neoplasia detection rates increase from 45 years of age.
    Karsenti D; Tharsis G; Burtin P; Venezia F; Tordjman G; Gillet A; Samama J; Nahon-Uzan K; Cattan P; Cavicchi M
    World J Gastroenterol; 2019 Jan; 25(4):447-456. PubMed ID: 30700941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fecal immunochemical testing results and characteristics of colonic lesions.
    van Doorn SC; Stegeman I; Stroobants AK; Mundt MW; de Wijkerslooth TR; Fockens P; Kuipers EJ; Bossuyt PM; Dekker E
    Endoscopy; 2015 Nov; 47(11):1011-7. PubMed ID: 26126163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Increasing Screening Age and Fecal Hemoglobin Cutoff Concentrations in a Colorectal Cancer Screening Program.
    Wieten E; Schreuders EH; Nieuwenburg SA; Hansen BE; Lansdorp-Vogelaar I; Kuipers EJ; Bruno MJ; Spaander MC
    Clin Gastroenterol Hepatol; 2016 Dec; 14(12):1771-1777. PubMed ID: 27567693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenoma Detection Rate and Risk for Interval Postcolonoscopy Colorectal Cancer in Fecal Immunochemical Test-Based Screening : A Population-Based Cohort Study.
    Wisse PHA; Erler NS; de Boer SY; den Hartog B; Oudkerk Pool M; Terhaar Sive Droste JS; Verveer C; Meijer GA; Lansdorp-Vogelaar I; Kuipers EJ; Dekker E; Spaander MCW
    Ann Intern Med; 2022 Oct; 175(10):1366-1373. PubMed ID: 36162114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Secondary Quality Indicator to Improve Prediction of Adenoma Miss Rate Apart from Adenoma Detection Rate.
    Aniwan S; Orkoonsawat P; Viriyautsahakul V; Angsuwatcharakon P; Pittayanon R; Wisedopas N; Sumdin S; Ponuthai Y; Wiangngoen S; Kullavanijaya P; Rerknimitr R
    Am J Gastroenterol; 2016 May; 111(5):723-9. PubMed ID: 26809333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High prevalence of advanced colorectal neoplasia in the Thai population: a prospective screening colonoscopy of 1,404 cases.
    Siripongpreeda B; Mahidol C; Dusitanond N; Sriprayoon T; Muyphuag B; Sricharunrat T; Teerayatanakul N; Chaiwong W; Worasawate W; Sattayarungsee P; Sangthongdee J; Prarom J; Sornsamdang G; Soonklang K; Wittayasak K; Auewarakul CU
    BMC Gastroenterol; 2016 Aug; 16(1):101. PubMed ID: 27553627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of a quarterly report card on colonoscopy quality measures.
    Kahi CJ; Ballard D; Shah AS; Mears R; Johnson CS
    Gastrointest Endosc; 2013 Jun; 77(6):925-31. PubMed ID: 23472996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adenoma Detection Rate and Colorectal Cancer Risk in Fecal Immunochemical Test Screening Programs : An Observational Cohort Study.
    Zorzi M; Antonelli G; Barbiellini Amidei C; Battagello J; Germanà B; Valiante F; Benvenuti S; Tringali A; Bortoluzzi F; Cervellin E; Giacomin D; Meggiato T; Rosa-Rizzotto E; Fregonese D; Dinca M; Baldassarre G; Scalon P; Pantalena M; Milan L; Bulighin G; Di Piramo D; Azzurro M; Gabbrielli A; Repici A; Rex DK; Rugge M; Hassan C; ; Giacomin A; Buda A; Costa D; Checchin D; Marin R; Patarnello E; Ceriani A; Guido E; Bertomoro P; Merlini N; Murer F; Ntakirutimana E; Benazzato L; Bellocchi MCC
    Ann Intern Med; 2023 Mar; 176(3):303-310. PubMed ID: 36802754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and variable detection of proximal colon serrated polyps during screening colonoscopy.
    Kahi CJ; Hewett DG; Norton DL; Eckert GJ; Rex DK
    Clin Gastroenterol Hepatol; 2011 Jan; 9(1):42-6. PubMed ID: 20888435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Findings in the distal colorectum are not associated with proximal advanced serrated lesions.
    Kahi CJ; Vemulapalli KC; Snover DC; Abdel Jawad KH; Cummings OW; Rex DK
    Clin Gastroenterol Hepatol; 2015 Feb; 13(2):345-51. PubMed ID: 25083562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A combination of clinical risk stratification and fecal immunochemical test results to prioritize colonoscopy screening in asymptomatic participants.
    Aniwan S; Rerknimitr R; Kongkam P; Wisedopas N; Ponuthai Y; Chaithongrat S; Kullavanijaya P
    Gastrointest Endosc; 2015 Mar; 81(3):719-27. PubMed ID: 25708760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).
    Zorzi M; Senore C; Da Re F; Barca A; Bonelli LA; Cannizzaro R; Fasoli R; Di Furia L; Di Giulio E; Mantellini P; Naldoni C; Sassatelli R; Rex D; Hassan C; Zappa M;
    Gut; 2015 Sep; 64(9):1389-96. PubMed ID: 25227521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Colorectal cancer detection in an asymptomatic population: fecal immunochemical test for hemoglobin vs. fecal M2-type pyruvate kinase.
    Caviglia GP; Cabianca L; Fagoonee S; Gili FM
    Biochem Med (Zagreb); 2016; 26(1):114-20. PubMed ID: 26981025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenoma detection rates in an opportunistic screening colonoscopy program in Iran, a country with rising colorectal cancer incidence.
    Delavari A; Bishehsari F; Salimzadeh H; Khosravi P; Delavari F; Nasseri-Moghaddam S; Merat S; Ansari R; Vahedi H; Shahbazkhani B; Saberifiroozi M; Sotoudeh M; Malekzadeh R
    BMC Gastroenterol; 2014 Nov; 14():196. PubMed ID: 25404264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ileal intubation is not associated with higher detection rate of right-sided conventional adenomas and serrated polyps compared to cecal intubation after adjustment for overall adenoma detection rate.
    Buerger M; Kasper P; Allo G; Gillessen J; Schramm C
    BMC Gastroenterol; 2019 Nov; 19(1):190. PubMed ID: 31730463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Difference in Physician- and Patient-Dependent Factors Contributing to Adenoma Detection Rate and Serrated Polyp Detection Rate.
    Cavicchi M; Tharsis G; Burtin P; Cattan P; Venezia F; Tordjman G; Gillet A; Samama J; Nahon-Uzan K; Karsenti D
    Dig Dis Sci; 2019 Dec; 64(12):3579-3588. PubMed ID: 31471862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.